Advertisement Home Diagnostics wins approval for blood glucose monitoring systems - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Home Diagnostics wins approval for blood glucose monitoring systems

Home Diagnostics has received 510(k) clearance from the FDA for the blood glucose meter, True2go, and for Trueresult, the company's latest advanced performance, no-coding meter for at-home testing.

According to the company, True2go offers patients the convenience of anywhere, on-the-go testing to help them better manage their diabetes, while Trueresult offers patients advanced monitoring capabilities at an affordable price.

The new True systems feature no-coding technology that simplifies blood glucose testing by eliminating the need for users to code the meter with each new box of test strips.

This advanced no-coding technology combined with a small sample size also makes it more convenient for diabetics to test their blood glucose levels more often, allowing for greater control of their glucose levels. True2go and Trueresult will be available in the fourth quarter of 2008.

Richard Damron, Jr, president and CEO of Home Diagnostics, said: “Our new product platform is designed to fit people’s needs whether they are testing at home or on-the-go, making it easier for them to test accurately and quickly.”